Hyperbaric Oxygen Therapy CPT Codes: Billing Guide for Providers & Patients

hbot cpt codes

Affiliate Disclosure

This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. This does not influence our evaluations or rankings.


How we evaluate: Our recommendations are based on published clinical evidence, manufacturer specifications, and real user feedback. We may earn a commission if you purchase through our links, at no extra cost to you. This does not influence our rankings.
Full disclosure.

The primary CPT code for hyperbaric oxygen therapy is 99183, which covers physician attendance and supervision of an HBOT session. The facility code is HCPCS G0277, billed in 30-minute segments. Together, these two codes account for nearly all HBOT billing in outpatient and clinic settings. As of 2025, Medicare reimburses physicians approximately $108-$137 per session (99183) and facilities $137.90 per 30-minute segment (G0277).12

$137.90Medicare G0277 facility fee per 30-minute HBOT segment (CY 2025), up from $132.21 in CY 2024UHMS 2025 CMS Payment Update

Primary CPT Code: 99183

$108-$137
Medicare rate for CPT 99183 (physician supervision)
$137.90
Medicare rate for G0277 per 30-min segment
3 units
G0277 units billed per typical 90-min session
15
Medicare-covered conditions requiring matching ICD-10

CPT code 99183 is defined as “physician or other qualified health care professional attendance and supervision of hyperbaric oxygen therapy, per session.” It is the professional-component code representing the clinical oversight provided during each treatment session.

What 99183 Covers

This code covers the physician’s active, in-person supervision during the session, including monitoring the patient’s physiological response, adjusting treatment parameters as needed, and managing any complications that arise under pressure. It does not cover facility costs, oxygen, or technical staff.

Reimbursement Rates (2025)

Payer Average Rate (CPT 99183) Notes
Medicare national average ~$108-$137 Varies by geographic locality
UnitedHealthcare $114-$126 Varies by provider/state
All-payer national average $174-$195 Range across major payers

The primary HBOT billing code (CPT 99183) reimburses physicians approximately $108-$137 per session, while the facility fee (G0277) adds $137.90 per 30-minute segment.”
PayerPrice.com, verified April 2026; UHMS 2025 CMS Payment Update

Facility Code: HCPCS G0277

G0277 covers “hyperbaric oxygen under pressure, full body chamber, per 30-minute interval.” This is the facility-side code accounting for the chamber, technical staff, monitoring equipment, and overhead. Treatment time runs from start of pressurization to end of depressurization. A typical 90-minute session is billed as 3 units of G0277 ($413.70 in 2025 at Medicare rates).

Hospital Outpatient Code: C1300

C1300 serves the same purpose as G0277 but is used in the hospital outpatient payment system under Ambulatory Payment Classifications (APCs). Also billed in 30-minute increments. Hospitals billing under OPPS use C1300 rather than G0277.

ICD-10 Codes Paired with HBOT Claims

Every HBOT claim must include a diagnosis code matching one of the 15 Medicare-covered indications. Without a matching ICD-10 code, the claim will be denied.

ICD-10 Code Description HBOT Indication
T70.3XXA Caisson disease (decompression sickness) Decompression illness
T59.7X1A Toxic effect of carbon monoxide, accidental Acute CO poisoning
T79.0XXA Air embolism (traumatic) Gas / air embolism
A48.0 Gas gangrene Gas gangrene
E11.621 Type 2 diabetes with foot ulcer Diabetic wounds (lower extremity)*
E10.621 Type 1 diabetes with foot ulcer Diabetic wounds (lower extremity)*
M86 (series) Osteomyelitis Chronic refractory osteomyelitis
T66.XXXA Radiation sickness, unspecified Osteoradionecrosis / soft tissue radionecrosis
M27.2 Inflammatory conditions of jaws Osteoradionecrosis (jaw)
K12.2 Cellulitis and abscess of mouth Actinomycosis (refractory)

*For diabetic wounds, Medicare requires both a diabetes ICD-10 code and a wound site code. The wound must be Wagner grade III+ and must have failed standard wound therapy before HBOT is approved.

15Medicare-covered conditions for HBOT under NCD 20.29. Claims outside this list are routinely denied.CMS National Coverage Determination 20.29, verified May 2026

Documentation Requirements for Reimbursement

Insufficient documentation is the leading cause of HBOT claim denials. Every treatment note must include:

  • A statement confirming the physician was physically present and actively supervising the session
  • Treatment pressure in atmospheres absolute (ATA)
  • Oxygen concentration delivered
  • Total session duration (start of pressurization to end of depressurization)
  • Patient clinical response and any adverse events
  • Clinical rationale linking treatment to a covered diagnosis

Prior Authorization

Many commercial insurers and some Medicare Advantage plans require prior authorization before HBOT begins. CMS also operates a prior authorization model for non-emergent HBOT in designated states. Starting treatment before authorization is secured places the provider at financial risk for the entire course.

For wound-related indications, document at least 30 days of standard wound care without adequate improvement before requesting authorization. For diabetic wounds, confirm and document Wagner grade III or higher.

For Patients: Understanding Your HBOT Bill

A typical HBOT bill includes two main charges per session. The physician supervision fee (CPT 99183) covers the doctor who monitored your treatment. The facility or chamber fee (G0277 or C1300) covers the time you spent in the chamber, billed in 30-minute increments. Additional services such as wound debridement appear as separate line items.

Before your first session: ask for the exact CPT and ICD-10 codes your provider plans to submit, confirm coverage and session limits with your insurer, and request prior authorization confirmation in writing. For full insurance coverage details, see our HBOT insurance coverage guide.

Medicare Cost Trends

The G0277 facility rate increased from $132.21 (CY 2024) to $137.90 (CY 2025), while the CMS conversion factor decreased from $33.29 to $32.35 (-2.8%). Physician reimbursement for 99183 decreased 37.8% from 2013 to 2022. Total Medicare cost per 40-session protocol fell 15.6% over the same period, from $27,562 to $23,834.3

Frequently Asked Questions

What is the CPT code for hyperbaric oxygen therapy?

The primary CPT code is 99183 (physician supervision per session). The facility code is HCPCS G0277, billed in 30-minute increments. A typical 90-minute session generates 1 unit of 99183 and 3 units of G0277.

Does Medicare cover hyperbaric oxygen therapy?

Yes, for 15 specific conditions under NCD 20.29. See our insurance coverage guide for the complete list and coverage criteria.

How many sessions does insurance typically cover?

For diabetic wounds, Medicare generally covers up to 30 sessions initially, with extensions if measurable improvement is documented. Commercial plans may set different limits. Confirm session limits with your insurer before starting treatment.

  1. PayerPrice. “CPT Code 99183 – Description and Fee Schedule 2026.” payerprice.com. Verified April 2026.
  2. UHMS. “2025 CMS Payment Update Highlights.” uhms.org. 2025.
  3. Gelly HB, Fife CE, Walker D, Eckert KA. “Trends in Medicare Costs of Hyperbaric Oxygen Therapy, 2013 through 2022.” Undersea & Hyperbaric Medicine. 2024. PMID: 38985150.
  4. CMS. “NCD – Hyperbaric Oxygen Therapy (20.29).” cms.gov. Verified May 2026.
  5. Undersea and Hyperbaric Medical Society. “HBO Therapy Indications.” uhms.org.
  6. Fife CE, Gelly HB, Walker D, Eckert KA. “Rapid analysis of hyperbaric oxygen therapy registry data for reimbursement purposes.” Undersea & Hyperbaric Medicine. 2016. PMID: 28768390.

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Why Trust Our Evaluations

Our rankings are based on hands-on testing, published clinical data, and verified manufacturer specifications. We apply the same criteria to every product regardless of affiliate status. Editorial Process · Evaluation Methodology

Previous Article

What to Expect During Hyperbaric Oxygen Therapy: First Session Guide

Next Article

Hyperbaric Oxygen Therapy Alternatives: EWOT, Ozone & How They Compare

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide